Don't miss out on our latest Highly Accessed Articles | Journal for ImmunoTherapy of Cancer

Dear Prof CERASALE MORTEO, We would like to recommend a selection of our highly accessed articles from Journal for ImmunoTherapy of Cancer. Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications. We hope that you find the articles below of interest and invite you to submit your next manuscript to the journal. Highly Accessed Articles REVIEW A New VISTA on combination therapy for negative checkpoint regulator blockade   Deng et al. Abstract   |  Full text   |  PDF RESEARCH ARTICLE A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma   Brohl et al. Abstract   |  Full text   |  PDF RESEARCH ARTICLE Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients   Nishino et al. Abstract   |  Full text   |  PDF New SITC Guidelines The Society for Immunotherapy of Cancer (SITC) has recently published guidelines for the use of immunotherapy to treat patients with prostate carcinoma, hematologic malignances, and renal cell carcinoma, as part of the Cancer Immunotherapy Guidelines series. These guidelines are the first of their kind and represent the result of a multidisciplinary collaboration between academic researchers and physicians, nurses, patients, and patients advocates from throughout the U.S. Reasons to Publish with Us • The official journal of the Society for ImmunoTherapy of Cancer (SITC) • Free article processing charges for SITC members • Distributed to over 15,000 individuals in the cancer treatment space and downloaded more than 800,000 times in 2015 Submit your manuscript Register to receive the latest articles, straight to your inbox. Best regards, The BioMed Central Team PS. Visit our website to find out more about open access funding options that may be available to you. SOCIETY AFFILIATION OFFICIAL JOURNAL OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC)

For further information or enquiries please contact Customer Services at:info@biomedcentral.com.

BioMed Central Ltd 

236 Gray's Inn Road, London, WC1X 8HB, 

United Kingdom.